A Griffith study has found childhood COVID vaccination leads to high reductions in child disease and mortality, but is more beneficial to adults, particularly the unvaccinated.
Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.
Using convalescent plasma, Griffith University researchers have identified how it may be possible to make a future vaccine that will provide protection against all major strains of COVID-19
Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.
Bendigo Bank Paradise Point Community Bank Branch, long-standing supporters of Griffith University’s Institute for Glycomics, have donated $10,000 in funding towards the Institute’s vital COVID-19 research, aiding their fight against the global pandemic. Four teams of expert scientists from the Institute for Glycomics are targeting SARS-CoV-2, the virus that causes COVID-19, to discover new vaccines […]